Drug profile · INN
aminosalicylate sodium
P.A.S. SODIUM
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
aminosalicylate sodium (P.A.S. SODIUM) is an FDA-listed pharmaceutical active ingredient. Associated with Solid Biosciences. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN aminosalicylate sodium
Brand P.A.S. SODIUM
Route ORAL
Formulation POWDER
Originator Solid Biosciences
Frequently asked questions
What is aminosalicylate sodium?
aminosalicylate sodium (P.A.S. SODIUM) is an FDA-listed pharmaceutical active ingredient. Associated with Solid Biosciences. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for aminosalicylate sodium?
P.A.S. SODIUM is a marketed brand name for aminosalicylate sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of aminosalicylate sodium?
aminosalicylate sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.